Dorling Janet

Insider profile

Dorling Janet's trades of Cymabay Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-02-14 2024-02-12 PlS Planned sale
27,073 +49.5%
489.25
US$4,284,104
27,073 +49.5% 489.25 US$4,284,104
2024-02-12 2024-02-12 PrS Proposed sale
50,239
311.93
US$2,388,920
50,239 311.93 US$2,388,920
2024-01-10 2024-01-10 PrS Proposed sale
15,987
409.07
US$913,055
15,987 409.07 US$913,055
2024-01-10 2024-01-10 PlS Planned sale
6,000 -100.0%
23.86
US$143,144
6,000 -100.0% 23.86 US$143,144
2023-12-11 2023-12-11 PrS Proposed sale
6,000
20.07
US$120,422
6,000 20.07 US$120,422
2023-12-11 2023-12-11 PlS Planned sale
6,000 -100.0%
20.07
US$120,422
6,000 -100.0% 20.07 US$120,422
2023-11-14 2023-11-10 PlS Planned sale
7,000 -100.0%
15.24
US$106,700
7,000 -100.0% 15.24 US$106,700
2023-11-13 2023-11-10 PrS Proposed sale
7,000
15.24
US$106,700
7,000 15.24 US$106,700
2019-02-25 2019-02-21 S Sale
1,063 -0.4%
0.89
US$946
1,063 -0.4% 0.89 US$946
2019-02-07 2019-02-05 S Sale
818 -0.3%
1.35
US$1,104
818 -0.3% 1.35 US$1,104
2018-06-28 2018-06-26 PlS Planned sale
450 -1.9%
9.59
US$4,316
450 -1.9% 9.59 US$4,316